Sylvie Perachon

1.2k total citations
10 papers, 985 citations indexed

About

Sylvie Perachon is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Social Psychology. According to data from OpenAlex, Sylvie Perachon has authored 10 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 2 papers in Social Psychology. Recurrent topics in Sylvie Perachon's work include Receptor Mechanisms and Signaling (8 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Sylvie Perachon is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Sylvie Perachon collaborates with scholars based in France, Germany and Ireland. Sylvie Perachon's co-authors include Pierre Sokoloff, Jean‐Charles Schwartz, Camille G. Wermuth, André Mann, Maria Pilla, Barry J. Everitt, François Sautel, Régis Bordet, Sophie Ridray and Holger Stark and has published in prestigious journals such as Nature, Journal of Medicinal Chemistry and Brain Research Reviews.

In The Last Decade

Sylvie Perachon

10 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Perachon France 8 716 578 116 115 101 10 985
Raymond P. Ward United States 7 715 1.0× 491 0.8× 66 0.6× 115 1.0× 114 1.1× 7 954
Manolo Mugnaini Italy 19 996 1.4× 881 1.5× 66 0.6× 64 0.6× 164 1.6× 28 1.4k
Deborah K. Hyslop United States 12 515 0.7× 324 0.6× 101 0.9× 93 0.8× 106 1.0× 19 900
J.W. Boja United States 12 1.3k 1.9× 852 1.5× 139 1.2× 56 0.5× 111 1.1× 24 1.5k
Michael J. Kuhar United States 19 729 1.0× 432 0.7× 127 1.1× 53 0.5× 158 1.6× 24 1.5k
Thomas J. Hudzik United States 18 445 0.6× 321 0.6× 49 0.4× 60 0.5× 94 0.9× 58 841
Leslie K. Chambers United States 7 563 0.8× 917 1.6× 86 0.7× 112 1.0× 70 0.7× 10 1.2k
Richard E. Chipkin United States 21 856 1.2× 559 1.0× 108 0.9× 67 0.6× 173 1.7× 52 1.3k
Kathy M. O’Boyle Ireland 21 1.0k 1.5× 719 1.2× 183 1.6× 65 0.6× 94 0.9× 36 1.4k
Hyacinth C. Akunne United States 24 1.0k 1.4× 925 1.6× 69 0.6× 248 2.2× 49 0.5× 49 1.5k

Countries citing papers authored by Sylvie Perachon

Since Specialization
Citations

This map shows the geographic impact of Sylvie Perachon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Perachon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Perachon more than expected).

Fields of papers citing papers by Sylvie Perachon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Perachon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Perachon. The network helps show where Sylvie Perachon may publish in the future.

Co-authorship network of co-authors of Sylvie Perachon

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Perachon. A scholar is included among the top collaborators of Sylvie Perachon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Perachon. Sylvie Perachon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Perachon, Sylvie, et al.. (2007). N‐(4‐(4‐(2‐Halogenophenyl)piperazin‐1‐yl)butyl) Substituted Cinnamoyl Amide Derivatives as Dopamine D2 and D3 Receptor Ligands. Archiv der Pharmazie. 340(4). 178–184. 8 indexed citations
2.
Mach, U, Sylvie Perachon, Sandrine Ferry, et al.. (2004). Development of Novel 1,2,3,4‐Tetrahydroisoquinoline Derivatives and Closely Related Compounds as Potent and Selective Dopamine D3 Receptor Ligands. ChemBioChem. 5(4). 508–518. 83 indexed citations
3.
Ghosh, Robin, Sylvie Perachon, André Mann, et al.. (2003). N-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as Dopamine D2 and D3 Receptor Ligands. Journal of Medicinal Chemistry. 46(18). 3883–3899. 95 indexed citations
4.
Sokoloff, Pierre, Bernard Le Foll, Sylvie Perachon, et al.. (2001). The dopamine D3 receptor and drug addiction. Neurotoxicity Research. 3(5). 433–441. 47 indexed citations
5.
Perachon, Sylvie, Catalina Betancur, Catherine Pilon, et al.. (2000). Role of dopamine D3 receptors in thermoregulation. Neuroreport. 11(1). 221–225. 33 indexed citations
6.
Perachon, Sylvie, Jean‐Charles Schwartz, & Pierre Sokoloff. (1999). Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors. European Journal of Pharmacology. 366(2-3). 293–300. 120 indexed citations
7.
Pilla, Maria, Sylvie Perachon, François Sautel, et al.. (1999). Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature. 400(6742). 371–375. 477 indexed citations
8.
Pilla, Maria, Sylvie Perachon, François Sautel, et al.. (1999). errata Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature. 401(6751). 403–403. 1 indexed citations
9.
Schwartz, J., Jorge Díaz, Régis Bordet, et al.. (1998). Functional implications of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence1Published on the World Wide Web on 24 November 1997.1. Brain Research Reviews. 26(2-3). 236–242. 117 indexed citations
10.
Sokoloff, Pierre, Jorge Díaz, Régis Bordet, et al.. (1998). [Function and therapeutic potential of the dopamine D3 receptor].. PubMed. 192(6). 1111–25. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raymond P. Ward Breakdown of academic impact, for papers by Manolo Mugnaini Breakdown of academic impact, for papers by Deborah K. Hyslop Breakdown of academic impact, for papers by J.W. Boja Breakdown of academic impact, for papers by Michael J. Kuhar Breakdown of academic impact, for papers by Thomas J. Hudzik Breakdown of academic impact, for papers by Leslie K. Chambers Breakdown of academic impact, for papers by Richard E. Chipkin Breakdown of academic impact, for papers by Kathy M. O’Boyle Breakdown of academic impact, for papers by Hyacinth C. Akunne
Rankless by CCL
2026